Researchers Start Untangling Warfarin Pharmacogenomics | GenomeWeb

NEW YORK (GenomeWeb News) – New research is dissecting the relative importance of polymorphisms in two genes linked to warfarin dose response.

In a study published online in the New England Journal of Medicine today, researchers from Vanderbilt University discussed how different variants contribute to warfarin response, influencing how long it takes patients to benefit from the treatment and to exceed the therapeutic dose.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.